The upside is not a pure semiconductor-cycle call. It comes from mix shifting toward higher-value advanced packaging, better utilization of new U.S. and Korea capacity, and tighter customer alignment through prepayments and multi-year programs. I assume only a moderate
rerating because Amkor still sells manufacturing services, but if it proves scarce qualified capacity rather than generic assembly, the equity can compound well above market norms.